Pinealon is synthetic short peptide marketed as a brain/pineal bioregulator. Researchers examine it in relation to neuronal stress, cognition and ageing hypotheses.

Researchers study whether it can affect nerve-cell stress, memory and age-related changes. Independent human evidence is sparse, so benefits remain unproven.

Proposed gene-regulatory and neuroprotective actions are based mainly on regional preclinical research.

Limited independently replicated primary evidence and no established international medicine authorisation.

No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.